SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-285506
Filing Date
2022-11-15
Accepted
2022-11-15 12:56:36
Documents
14
Period of Report
2022-11-15
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d305516d8k.htm   iXBRL 8-K 41998
2 EX-99.1 d305516dex991.htm EX-99.1 18248
  Complete submission text file 0001193125-22-285506.txt   244250

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA flac-20221115.xsd EX-101.SCH 3404
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE flac-20221115_def.xml EX-101.DEF 14818
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE flac-20221115_lab.xml EX-101.LAB 25104
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE flac-20221115_pre.xml EX-101.PRE 15818
8 EXTRACTED XBRL INSTANCE DOCUMENT d305516d8k_htm.xml XML 7794
Mailing Address TWO UNION SQUARE, 601 UNION STREET SUITE 3200 SEATTLE WA 98101
Business Address TWO UNION SQUARE, 601 UNION STREET SUITE 3200 SEATTLE WA 98101 617-570-8364
Frazier Lifesciences Acquisition Corp (Filer) CIK: 0001828326 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39765 | Film No.: 221390309
SIC: 6770 Blank Checks